Your session is about to expire
← Back to Search
ACT + Care Management App for Opioid Use Disorder
Study Summary
This trial will test if a combination of therapies can help those with both chronic pain and opioid addiction. The therapies include Acceptance and Commitment Therapy, as well as a care management smartphone app. Those affected will be engaged in all stages of the research.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I experience moderate to severe chronic pain.I haven't changed my mental health medications in the last 3 months.I started seeing a therapist for mental health within the last 3 months.You are currently using a health app on your smartphone that works like the Valera app.I do not have any mental conditions that would stop me from using online health services.I have undergone ACT or a similar therapy before.I am 18 years old or older.I have been on a stable dose of BUP for OUD treatment at Montefiore for over a month.I am proficient in English or Spanish.My cancer is causing my current pain.You are currently experiencing severe mental health issues that make it difficult for you to take part in the study, such as extreme mood swings, thoughts of hurting yourself or others, or losing touch with reality.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies left for participation in this research project?
"Clinicaltrials.gov confirms that this trial, initially posted on November 1st 2022 and last modified on October 19th 2022 is no longer recruiting patients. While the search for participants has been concluded, there are 664 other trials seeking enrollees at present."
What is the projected result of this research endeavor?
"The primary metric for success of this 24 week trial is Pain interference. Secondary goals include assessing Substance use urges with the AAQ-SA, urine toxicology tests to measure Substance use, and ASI testing to gauge off-opioid Substance consumption."
Share this study with friends
Copy Link
Messenger